Oǧuzhan Doǧanlar

Prof. Dr. Oǧuzhan Doǧanlar

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2016 in Life Sciences
Verified
Journal Article
Closed access
SESuat Erdogan
Suat Erdogan
ODOǧuzhan Doǧanlar
Oǧuzhan Doǧanlar
ZDZeynep B. Doganlar
Zeynep B. Doganlar
RSRıza Serttaş
Rıza Serttaş
KTKader Turkekul
Kader Turkekul
ABAyhan Bilir
Ayhan Bilir

1 November 2018 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
SESuat Erdogan
Suat Erdogan
KTKader Turkekul
Kader Turkekul
IDIlker Dibirdik
Ilker Dibirdik
ODOǧuzhan Doǧanlar
Oǧuzhan Doǧanlar
ZDZeynep B. Doganlar
Zeynep B. Doganlar
GOGulperi Oktem
Gulperi Oktem

1 December 2018 in Prostate International
Verified
Journal Article
Open access
SESuat Erdogan
Suat Erdogan
ODOǧuzhan Doǧanlar
Oǧuzhan Doǧanlar
ZDZeynep B. Doganlar
Zeynep B. Doganlar
KTKader Turkekul
Kader Turkekul
The aim of the study was to evaluate whether the use of chemotherapy in combination with naringin, a dietary plant polyphenolic flavonoid, could enhance the therapeutic efficacy of paclitaxel treatment in human prostate cancer (PCa) cells. DU145, PC3, and LNCaP cells were treated with various concentrations of paclitaxel, naringin, and their combinations. Methylthiazolyldiphenyl-tetrazolium bromide (MTT), image-based cytometer, quantitative reverse transcription PCR (RT-qPCR), Western blot, and transwell assay were used to evaluate cell viability, apoptosis and cell cycle, the mRNA expression, protein expression, and cell migration, respectively. Naringin treatment inhibited cell survival in a dose- and time-dependent manner by inducing apoptosis and cell cycle arrest in G1 phase. Among the pathways evaluated, naringin (150 μM) significantly induced the mRNA expressions of BAX, BID, caspase 3, cytochrome c, p53, p21 Cip1 , and p27 Kip1 and downregulated the expressions of survivin and livin in DU145 cells. The combination of naringin and paclitaxel treatments synergistically increased the cytotoxic effects of paclitaxel in androgen-independent DU145 and PC3 cells, as well as in androgen-sensitive LNCaP cells. The combination of naringin with docetaxel has almost the same inhibitory effect on cell proliferation as the paclitaxel combination in androgen-independent cells, whereas there is no similar effect in LNCaP cells. Naringin exhibits significant inhibitory effects on the cell migration ability. The flavonoid either alone or in combination with paclitaxel therapy resulted in an increase in tumor suppressor PTEN (phosphatase and tensin homolog deleted on chromosome 10) protein expression and decrease in nuclear factor-κB p50 protein level in DU145 cells. In conclusion, naringin acts as a chemosensitizer which synergistically strengths the cytotoxic effect of paclitaxel in PCa cells. Therefore, naringin therapy alone or in combination with paclitaxel may be useful in the treatment of PCa. However, there is a need for more detailed in vivo studies of the mechanism of action.

26 September 2020 in Biochemical Genetics
Verified
Journal Article
Closed access
PDF file
DADoğan Albayrak
Doğan Albayrak
ODOǧuzhan Doǧanlar
Oǧuzhan Doǧanlar
SESuat Erdoğan
Suat Erdoğan
MMMeryem Meraklı
Meryem Meraklı
ADAyten Doğan
Ayten Doğan
ZDZeynep Banu Doğanlar
Zeynep Banu Doğanlar

12 July 2018 in Archives of Environmental Contamination and Toxicology
Verified
Journal Article
Closed access
PDF file
ZDZeynep Banu Doğanlar
Zeynep Banu Doğanlar
ODOǧuzhan Doǧanlar
Oǧuzhan Doǧanlar
HTHilmi Tozkir
Hilmi Tozkir
FGFulya Dilek Gökalp
Fulya Dilek Gökalp
ADAyten Doğan
Ayten Doğan
ÜAÜmmühan Ersin Aktaş
Ümmühan Ersin Aktaş

16 April 2019 in Investigational New Drugs
Verified
Journal Article
Closed access
PDF file
SESuat Erdogan
Suat Erdogan
KTKader Turkekul
Kader Turkekul
IDIlker Dibirdik
Ilker Dibirdik
ZDZeynep B. Doganlar
Zeynep B. Doganlar
ODOǧuzhan Doǧanlar
Oǧuzhan Doǧanlar
ABAyhan Bilir
Ayhan Bilir